Journal of Ai ML DL
Journal of Ai ML DL

Publishing Policies

The Journal of Ai ML DL is committed to upholding the highest standards of academic integrity, transparency, and ethical publishing. The policies below guide our editorial practices, author responsibilities, and compliance requirements.


1. Editorial Policy

The Journal of Ai ML DL adheres to the principles of the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and relevant domain-specific ethical frameworks. All submissions undergo rigorous review for scientific merit, ethical compliance, and relevance to the journal's scope.

Submission implies that:

  • The manuscript is original and not under consideration elsewhere.

  • All authors have approved the content.

  • All ethical and institutional requirements have been fulfilled.


2. Authorship

Authorship should reflect significant contributions to the conception, design, execution, or interpretation of the research. All listed authors must:

  • Approve the final manuscript.

  • Accept responsibility for the content.

  • Disclose any conflicts of interest.

Please refer to our detailed Author Guidelines for authorship criteria and contributor roles.


3. Publication Ethics

We follow COPE's Core Practices and GPP3 guidelines to ensure integrity in publication. Authors, reviewers, and editors are expected to:

  • Avoid fabrication, falsification, and plagiarism.

  • Disclose all conflicts of interest.

  • Report errors, ethical concerns, or misconduct post-publication.

All ethical breaches will be investigated and addressed in accordance with COPE procedures.


4. Patient Identity / Informed Consent

Manuscripts containing identifiable patient information must include:

  • Proof of informed consent from the patient or legal guardian.

  • Anonymization of all nonessential identifying data.

  • A consent statement in the manuscript.

ICMJE and WHO consent form templates are recommended. Consent forms must be archived by the authors and made available on request.


5. Ethical Approval of Human Research

All human-subject research must:

  • Comply with the Declaration of Helsinki.

  • Receive approval from an Institutional Review Board (IRB) or equivalent.

  • Include a clear ethics statement in the manuscript.


6. Ethical Approval for Use of Human Cell Lines and Tissues

When using human biospecimens:

  • Include ethics committee approval.

  • Confirm donor consent.

  • Name the source (e.g., commercial provider or biobank).

  • Provide rationale if consent or ethics approval was not obtained.


7. Case Reports / Case Series / Clinical Datasets

All such studies must:

  • Be approved by an IRB unless exempt by institutional policy.

  • Include patient consent for identifiable information.

  • Follow COPE guidelines on publishing case reports.

Retrospective studies involving fewer than three patients may not require ethics approval but must comply with local regulations.


8. Ethical Approval of Animal Research

All animal studies must:

  • Follow institutional, national, and international animal welfare guidelines.

  • Be approved by an animal ethics committee.

  • Include a statement of ethics approval.

  • Comply with ARRIVE and NC3Rs guidelines (particularly for non-human primates or client-owned animals).


9. Ethics Approval and Consent Requirements for Research

Authors must ensure:

  • IRB/ethics committee approval for any research involving humans, animals, or biological materials.

  • Explicit consent for identifiable human data.

  • Statement of exemption where applicable.

  • Inclusion of ethics declarations in the Methods section.


10. Peer Review

We use a single-blind peer review model.

10.1 Peer Review Workflow:

  1. Submission → Editorial screening

  2. Initial Assessment by Editor-in-Chief

  3. Reviewer Assignment (2–4 reviewers)

  4. Review Period: 2–3 weeks

  5. Editorial Decision: Accept / Revise / Reject

  6. Revision & Re-review: If needed

  7. Final Decision by Editor-in-Chief

  8. Copyediting & Proofreading

  9. Publication

10.2 Portability of Peer Review

Reviews may be transferred between related journals upon author approval. Editors may consult with other journal editors regarding transfer suitability. Reviewers who do not wish their reports reused must declare so.


11. Special Issue Policy

Special issues are managed by invited Guest Editors, in coordination with the journal’s Editorial Board. All submissions undergo the standard peer-review process.

11.1 Special Issue Workflow:

  • Define theme and scope.

  • Appoint qualified Guest Editors.

  • Announce a Call for Papers.

  • Conduct rigorous peer review.

  • Final decisions by Guest Editor (appeals to Editor-in-Chief).

  • Prepare issue layout, promote post-publication.


12. Conference Abstract Policy

Conference abstracts are evaluated jointly by Section Editors and conference committees. Criteria include:

  • Scientific rigor

  • Relevance to conference theme

  • Novelty

  • Quality of writing

Accepted abstracts are:

  • Assigned DOIs

  • Indexed

  • Published with editorial oversight


13. Corrigendum Policy

Corrections post-publication must follow strict guidelines.

Minor Fixes Without Corrigendum:

  • Non-substantive typos

  • Layout issues

Corrigendum Required:

  • Changes in results, authorship, title, affiliations

  • Submitted via email with details of original and corrected text

  • A $190 fee applies for discretionary corrections not caused by the publisher

Published corrigenda:

  • Linked to the original article

  • Indexed and archived


14. Retraction Policy

Following COPE guidelines, retractions are reserved for:

  • Proven misconduct (plagiarism, falsification)

  • Major errors invalidating results

  • Ethical violations

Retraction Process:

  • Initiated by authors or editors

  • Investigated by editorial leadership

  • Result in a formal retraction notice

  • Indexed and linked to the original article

Alternatives include corrigenda or expressions of editorial concern.


15. Declaration of AI Tool Usage

Authors must disclose the use of AI tools (e.g., ChatGPT, Copilot, etc.) during manuscript preparation. Following COPE’s AI policy:

  • AI tools cannot be listed as authors.

  • Use must be described in Methods or Acknowledgments.

  • Authors take full responsibility for AI-generated content.


16. Digital Archiving Policy

To ensure long-term preservation, Journal of Ai ML DL archives content with:

  • National Library of Australia (NED)

  • Internet Archive

  • Institutional repositories

All content is:

  • Open-access under CC BY 4.0

  • Assigned a DOI

  • Stored in XML/Dublin Core metadata format

The archiving policy is periodically reviewed for compliance with international standards.


17. Repository Policy

Authors are permitted to archive:

  • Postprints (peer-reviewed, before typesetting): Anywhere, immediately upon acceptance.

  • Published Versions: On personal, institutional websites with a citation and journal link.

Preprints Policy:

  • Preprints are not permitted.

  • Contact editorial office for clarification prior to submission.

The journal complies with funder open-access mandates and supports repository deposition aligned with CC BY 4.0.


Please direct any inquiries to:
office@emanresearch.org